Home / Share Price Target / Aartidrugs
Aarti Drugs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Aarti Drugs Limited | |||
 | Symbol: AARTIDRUGS | ||
| Price: ₹453.1 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Aarti Drugs Brief Company Overview
- 1.1: Aarti Drugs Limited: A Comprehensive Overview
- 1.2: Aarti Drugs Financial Performance
- 1.2.1: Is Aarti Drugs A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Aarti Drugs Share Price Target For 2024
- 2.1.1: Aarti Drugs Share Price Target Table For 2024
- 2.1.2: Summary: Aarti Drugs Share Price Prediction For 2024
- 2.2: Aarti Drugs Share Price Target For 2025
- 2.2.1: Aarti Drugs Share Price Target Table For 2025
- 2.2.2: Summary: Aarti Drugs Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Aarti Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Aarti Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Aarti Drugs Past Performance
Aarti Drugs Brief Company Overview
Aarti Drugs Limited: A Comprehensive Overview
Established in 1984, Aarti Drugs Limited is a renowned manufacturer and marketer of pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations. With a global presence, Aarti Drugs caters to a diverse range of therapeutic areas, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antidiabetics, and Alzheimer's treatment.
The company's commitment to innovation is evident in its wide product portfolio. Aarti Drugs offers over 200 products, spanning antibiotics, antifungals, antiarthritis, vitamins, and sedatives. Its specialty chemical products include benzene sulphonyl chloride, benzene sulphonic acid, and formamide. Additionally, the company is developing promising products such as Itraconazole, Fluconazole, and Dabigatran.
Aarti Drugs' reputation in the industry is built on its emphasis on quality and customer satisfaction. The company's state-of-the-art facilities and stringent regulatory compliance ensure that its products meet the highest standards. Aarti Drugs is known for its reliable supply chain, competitive pricing, and exceptional customer service.
Headquartered in Mumbai, India, Aarti Drugs Limited has established a strong global presence with operations in over 50 countries. The company's unwavering commitment to research, development, and exceptional service has made it a trusted partner for healthcare professionals and patients worldwide.
Aarti Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 4,265.95 Crore | Market valuation of Aarti Drugs's shares. |
| Revenue (TTM) | 2,379.6 Crore | Total revenue generated by Aarti Drugs over the past twelve months. |
| Net Income (TTM) | +152.22 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 9.15% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 6.39% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -6.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -11.61% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 46.18 | Company's total debt divided by total shareholder equity. |
| Total Debt | 590.1 Crore | Sum of Aarti Drugs's current & long-term financial obligations. |
| Total Cash | 29.56 Crore | Total amount of liquid funds available to Aarti Drugs. |
| Beta | 0.82 | Beta is less than 1 indicating that the Aarti Drugs's price is less volatile than the market. |
Is Aarti Drugs A Good Buy For Long Term?
Aarti Drugs, a small-cap stock with a market capitalization of ₹4,265.95 crore, presents a mixed picture for long-term investors. While its ₹2,379.6 crore revenue (TTM) and ₹152.22 crore net profit are noteworthy, a declining profit margin (6.39%) and negative year-on-year earnings growth (-11.61% in Q2 2024-25) raise concerns. The significant debt (₹590.1 crore) against a low cash balance (₹29.56 crore) further adds to the risk. Although past 5-year returns are positive (212.41%), recent performance has been weak (-8.17% YTD, -36.32% over 3 years). Therefore, it's currently a not a good buy for long-term investment. Further analysis is recommended before considering any investment.
To predict the Aarti Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Aarti Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Aarti Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aarti Drugs shares in 2024, see the table below.
Aarti Drugs Share Price Target Table For 2024
| Aarti Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 466.10 (+2.86%) | Price Action: 25 Oct 2024 Low |
| 2024 Target 2 | 460.89 (+1.71%) | Price Action: 21 Nov 2024 High |
| 2024 Target 1 | 455.66 (+0.56%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 453.10 | Aarti Drugs's 1 share price as of Mon 25 Nov 2024 |
| Stop Loss 1 | 452.31 (-0.18%) | Price Action: Chart |
| Stop Loss 2 | 447.08 (-1.33%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 441.90 (-2.48%) | Price Action: Oct 2022 Low |
Summary: Aarti Drugs Share Price Prediction For 2024
In summary, Aarti Drugs has declined by ₹-36.10, recording a notable -7.38% decrease from 1st January 2024 to 25 Nov 2024. Despite the setback, our analysis of Aarti Drugs for 2024 predicts an additional rise of 0.56% to 2.86% by the end of 2024 with three potential targets T1: 455.66, T2: 460.89, T3: 466.10. Stop Loss at SL1: 452.31, SL2: 447.08, SL3: 441.90.
Aarti Drugs has a 52-week high of ₹635.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹431.04, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Aarti Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aarti Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Aarti Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aarti Drugs shares in 2025, see the table below.
Aarti Drugs Share Price Target Table For 2025
| Aarti Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 572.63 (+26.38%) | Price Action: Chart |
| 2025 Target 2 | 561.95 (+24.02%) | Price Action: Chart |
| 2025 Target 1 | 556.39 (+22.79%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 453.10 | Aarti Drugs's 1 share price as of Mon 25 Nov 2024 |
| Stop Loss 1 | 429.45 (-5.22%) | Price Action: Feb 2023 High |
| Stop Loss 2 | 422.85 (-6.68%) | Price Action: May 2023 Low |
| Stop Loss 3 | 418.50 (-7.64%) | Price Action: Mar 2022 Low |
Summary: Aarti Drugs Share Price Prediction For 2025
In summary, Aarti Drugs has declined by ₹-36.10, recording a notable -7.38% decrease from 1st January 2024 to 25 Nov 2024. Despite the setback, our analysis of Aarti Drugs for 2025 predicts an additional rise of 22.79% to 26.38% by the end of 2025 with three potential targets T1: 556.39, T2: 561.95, T3: 572.63. Stop Loss at SL1: 429.45, SL2: 422.85, SL3: 418.50.
Aarti Drugs has a All-Time high of ₹1026.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹431.04, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Aarti Drugs, we have created a specific page for that check here: Aarti Drugs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Aarti Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Aarti Drugs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 3% over the next 15 years.
For complete year by year Aarti Drugs long term share price target from 2024, 2025 to 2039 check the below table.
Aarti Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Aarti Drugs Target | YoY Change % |
|---|---|---|
| 2024 | ₹453.1 | [Current Price] |
| 2024 | ₹525.7 | 16.02% |
| 2025 | ₹527.46 | 0.33% |
| 2026 | ₹542.73 | 2.89% |
| 2027 | ₹643.82 | 18.62% |
| 2028 | ₹650.45 | 1.02% |
| 2029 | ₹626.38 | -3.71% |
| 2030 | ₹624.75 | -0.27% |
| 2031 | ₹639.28 | 2.32% |
| 2032 | ₹754.41 | 18% |
| 2033 | ₹758.47 | 0.53% |
| 2034 | ₹727.06 | -4.15% |
| 2035 | ₹722.04 | -0.7% |
| 2036 | ₹735.82 | 1.9% |
| 2037 | ₹865.01 | 17.55% |
| 2038 | ₹866.49 | 0.17% |
| 2039 | ₹795.11 | -8.24% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aarti Drugs Past Performance
- In 1995, Aarti Drugs opening price was ₹6.46
- As of Mon 25 Nov 2024 the price stands at ₹453.1.
- This represents a Compound Annual Growth Rate (CAGR) of 15.22%.
- In 29 years, an investment of 10,000 would have become ₹7.01 Lakh.
As we wrap up, we hope you like our study on Aarti Drugs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Aarti Drugs Share Price History
- Aarti Drugs Price Target Tomorrow
- Aarti Drugs Dividend History
- Aarti Drugs Bonus History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
